
Hannes Boelsen
Johannes Gutenberg-Universität Mainz, Philosophisches Seminar, Graduate Student & Student Research Assistant
I'm currently a graduate student of philosophy and a student research assistant (lecturer for argumentation theory and tutor for scientific propaedeutics) at Johannes Gutenberg University of Mainz, Germany. I hold a Bachelors degree in german studies and philosophy. My research centers on neuroethics (psychopharmacological cognitive enhancement), neurophilosophy, philosophy of cognitive (neuro-)science (mechanistic explanation & philosophy of predictive processing), and philosophy of mind (mental representation).
less
Papers
Frontiers in Pharmacology, 2018
Pharmacological cognitive enhancement (PCE), the use of illicit and/or prescription drugs to incr... more Pharmacological cognitive enhancement (PCE), the use of illicit and/or prescription drugs to increase cognitive performance, has spurred controversial discussion in bioethics. In a semi-structured interview study with 60 German university students and employees, differences and similarities in moral attitudes toward PCE among 30 experienced participants (EPs) vs. 30 inexperienced participants (IPs) were investigated. Substances EPs used most often are methylphenidate, amphetamines, tetrahydrocannabinol and modafinil. Both EPs and IPs addressed topics such as autonomous decision making or issues related to fairness such as equality in test evaluation and distortion of competition. While most EPs and IPs were convinced that the decision of whether or not to use PCE is part of their individual freedom, their views varied considerably with regard to fairness. IPs considered issues related to fairness as much more critical than EPs. Thus, a person’s moral attitudes toward PCE may not only depend on moral common sense, but also on whether they have used illegal and/or prescription drugs for PCE before. This points to the importance of including the various relevant stakeholder perspectives in debates on the ethical and social implications of PCE.
Open Mind: Philosophy and the Mind Sciences in the 21st Century
This commentary is the first case study in the applied metascience of neuroethics, that is, the a... more This commentary is the first case study in the applied metascience of neuroethics, that is, the application of a metascientific approach to neuroethical research. I apply a bottom-up approach to neuroethics to Churchland’s publication. The bottom-up approach to neuroethics is a quantitative approach (based on scientometric methods) that, among other things, allows us to outline the field from 1995 until 2012 through the development of fifteen subject-categories or topic prototypes. Each subject-category or topic prototype is defined by up to thirty-one keywords that appear frequently in the abstracts and titles of the publications in the Mainz neuroethics bibliography. The connection strength between two subject-categories or topic prototypes depends upon the number of shared publications, that is, the number of publications that can be assimilated to both subject-categories or topic prototypes. Accordingly, a keyword-based search of the abstract and title of any publication in neuroethics allows us to assimilate it to (at least) one subject-category or topic prototype and, thereby, localize it within neuroethics and reveal its degrees of relevance to neuroethical research, as measured by the connection strengths between the subject-categories or topic prototypes. A case study on Churchland’s publication led to the following results: the publication is localized in the subject-category or topic prototype Moral Theory, has high degrees of relevance to research that can be assimilated to the subject-categories or topic prototypes Neuroimaging, Philosophy of Mind and Consciousness, and Economic and Social Neuroscience, and has low degrees of relevance to research that can be assimilated to the subject-categories or topic prototypes Addiction, Brain Death and Severe Disorders of Consciousness, Brain Stimulation, Enhancement, Legal Studies, (Medical) Research and Medicine, Molecular Neurobiology and Genetics, Neuroscience and Society, Neurosurgery, Psychiatric and Neurodegenerative Diseases and Disorders, and Psychopharmacology. Such results can be fed back into neuroethical research, which, in turn, can optimize neuroethics itself and, hence, improve our pursuit of moral understanding. The take-home messages are as follows: potential follow-up studies on Churchland’s publication should consider my case-study results and analysis and, furthermore, future neuroethical research should be more careful to take applied metascience of neuroethics into account. This can be done at different stages of research. If this general idea is on the right track, then applied metascience of neuroethics is complementary to (and perhaps even extends) Churchland’s argument, only on a different level.
Frontiers in Pharmacology, 2018
Pharmacological cognitive enhancement (PCE), the use of illicit and/or prescription drugs to incr... more Pharmacological cognitive enhancement (PCE), the use of illicit and/or prescription drugs to increase cognitive performance, has spurred controversial discussion in bioethics. In a semi-structured interview study with 60 German university students and employees, differences and similarities in moral attitudes toward PCE among 30 experienced participants (EPs) vs. 30 inexperienced participants (IPs) were investigated. Substances EPs used most often are methylphenidate, amphetamines, tetrahydrocannabinol and modafinil. Both EPs and IPs addressed topics such as autonomous decision making or issues related to fairness such as equality in test evaluation and distortion of competition. While most EPs and IPs were convinced that the decision of whether or not to use PCE is part of their individual freedom, their views varied considerably with regard to fairness. IPs considered issues related to fairness as much more critical than EPs. Thus, a person’s moral attitudes toward PCE may not only depend on moral common sense, but also on whether they have used illegal and/or prescription drugs for PCE before. This points to the importance of including the various relevant stakeholder perspectives in debates on the ethical and social implications of PCE.
Open Mind: Philosophy and the Mind Sciences in the 21st Century
This commentary is the first case study in the applied metascience of neuroethics, that is, the a... more This commentary is the first case study in the applied metascience of neuroethics, that is, the application of a metascientific approach to neuroethical research. I apply a bottom-up approach to neuroethics to Churchland’s publication. The bottom-up approach to neuroethics is a quantitative approach (based on scientometric methods) that, among other things, allows us to outline the field from 1995 until 2012 through the development of fifteen subject-categories or topic prototypes. Each subject-category or topic prototype is defined by up to thirty-one keywords that appear frequently in the abstracts and titles of the publications in the Mainz neuroethics bibliography. The connection strength between two subject-categories or topic prototypes depends upon the number of shared publications, that is, the number of publications that can be assimilated to both subject-categories or topic prototypes. Accordingly, a keyword-based search of the abstract and title of any publication in neuroethics allows us to assimilate it to (at least) one subject-category or topic prototype and, thereby, localize it within neuroethics and reveal its degrees of relevance to neuroethical research, as measured by the connection strengths between the subject-categories or topic prototypes. A case study on Churchland’s publication led to the following results: the publication is localized in the subject-category or topic prototype Moral Theory, has high degrees of relevance to research that can be assimilated to the subject-categories or topic prototypes Neuroimaging, Philosophy of Mind and Consciousness, and Economic and Social Neuroscience, and has low degrees of relevance to research that can be assimilated to the subject-categories or topic prototypes Addiction, Brain Death and Severe Disorders of Consciousness, Brain Stimulation, Enhancement, Legal Studies, (Medical) Research and Medicine, Molecular Neurobiology and Genetics, Neuroscience and Society, Neurosurgery, Psychiatric and Neurodegenerative Diseases and Disorders, and Psychopharmacology. Such results can be fed back into neuroethical research, which, in turn, can optimize neuroethics itself and, hence, improve our pursuit of moral understanding. The take-home messages are as follows: potential follow-up studies on Churchland’s publication should consider my case-study results and analysis and, furthermore, future neuroethical research should be more careful to take applied metascience of neuroethics into account. This can be done at different stages of research. If this general idea is on the right track, then applied metascience of neuroethics is complementary to (and perhaps even extends) Churchland’s argument, only on a different level.